BIOTECanada: State of the Industry 2004

The annual survey on revenues and the issues they face in commercializing products states that there are over 450 Canadian biotechs in areas such as vaccines, stem cell research and plant biotech. In 2003, $1.9 billion was invested into the Canadian biotech sector, the majority of which went to public companies, leaving $242.4 million for private biotech companies.